| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |